Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Phase I/II Clinical Trial of Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Glioblastoma (GBM) Patients
Brief Summary:
The goal of Phase I of this clinical research study is to find the highest tolerable dose of cytomegalovirus cytotoxic T lymphocytes (CMV CTLs) that can be given in combination with temozolomide to patients with glioblastoma.
The goal of Phase II of this study is to learn if CMV CTLs combined with temozolomide can help to control glioblastoma. The safety of this combination will also be studied.